Improving Breast Cancer Risk Prediction with Estradiol Levels
Author Information
Author(s): Bernard Rosner, Graham A Colditz, J Dirk Iglehart, Susan E Hankinson
Primary Institution: Brigham and Women's Hospital and Harvard Medical School
Hypothesis
Does the addition of estradiol levels improve breast cancer risk prediction models?
Conclusion
Estradiol levels in postmenopausal women significantly enhance the prediction of breast cancer risk.
Supporting Evidence
- The addition of estradiol levels improved the C statistic from 0.635 to 0.645.
- 1,559 invasive estrogen receptor-positive breast cancer cases were confirmed during the study.
- Plasma estradiol levels were significantly associated with breast cancer risk.
- The study used a large cohort of female nurses for data collection.
- Imputed estradiol levels were derived from a nested case-control study.
Takeaway
This study found that measuring estradiol levels can help predict breast cancer risk better, especially for women after menopause.
Methodology
The study used linear regression and multiple imputation methods to develop a risk model incorporating estradiol levels and other risk factors.
Potential Biases
Potential bias due to the small size of the nested case-control study affecting the precision of estimates.
Limitations
Not all participants had measured estradiol levels, and the nested case-control study had a small sample size.
Participant Demographics
The study involved 59,812 female nurses aged 30 to 55 years at baseline, followed from 1980 to 2000.
Statistical Information
P-Value
<0.001
Confidence Interval
1.8 to 6.0
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website